Fairvalue-Calculator Fairvalue-Calculator
EN DE

Nanologica AB (NICA) Fair Value & Analysis

Healthcare · SE · Market cap 174M SEK

Pricekr 0.5460
Fair Valuekr 0.3100
Upside-43.2%
Quality95/100
Evidence: Low Range kr 0.2300 – kr 0.3900

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Nanologica AB (NICA) currently trades at kr 0.5460, while our model-based Fair Value estimate is kr 0.3100 — implying the stock looks roughly 43.2% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Nanologica AB (publ), a life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally. The company offers NLAB Saga, a silica-based purification media for preparative chromatography that is developed for the purification of peptide drugs, such as insulin and GLP-1 analogues; NLAB Idun, an ion exchange product for robust, reproducible, and efficient downstream purification of GLP-1 analogues and other peptides; NLAB Idun SP, a strong cation exchanger with sulfopropyl groups as ligands; NLAB Idun Q, a strong anion exchanger with a quaternary amine ligand; and NLAB Siv, a non-silica-based media for purification by preparative chromatography used for products outside the peptide range. It also provides high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces; and analytical chromatography, an analysis metho…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Nanologica AB (NICA) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 0.3100 versus a price of kr 0.5460 — about −43% (overvalued). Model-based estimate, not financial advice.
What is the fair value of NICA?
Our 21-model fair value for Nanologica AB is kr 0.3100 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 0.5460.
What is the quality score of NICA?
Nanologica AB has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.